Skip to content
Westlake BioPartners
  • People
  • Portfolio
  • About
  • News
  • Contact
Westlake BioPartners
  • People
  • Portfolio
  • About
  • News
  • Contact

Investing in People With Vision

It takes a village to bring life-saving medicines to market, so we invest in entrepreneurs to create companies that turn breakthroughs into treatments for patients in need. 

W Hero Image

We Put People First

Westlake BioPartners is a people-first life science VC firm that crafts companies around world-class entrepreneurs. Immersed in the Los Angeles biotech community we helped catalyze, we’re intentionally scaled to incubate only the most promising companies by complementing their teams with personal attention, hands-on support, and connections to the most impactful innovations of our time. We believe it takes more than just great science to make life-changing medicines and by putting people first, we serve the greatest unmet patient needs.

Get to Know Our People

Our Entrepreneurs Making a Difference

Catherine Pearce, CEO

Catherine Pearce,
CEO

AllRock Bio

Advancing impactful therapies for cardio­pulmonary diseases.

Christian Hordo, CEO

Christian Hordo,
CEO

Borealis Biosciences

Next-generation RNA medicines for kidney disease.

Company We’re Proud to Keep

The Westlake Way

We know people are the first and most valuable asset. Our approach focuses on empowering the right entrepreneurs and guiding them through growth from ideation and preclinical research to clinical and commercial impact for the treatment of patients. We’re intentionally scaled to foster close relationships with our founders, take action instead of offer opinions, and deepen harmonious connections in our entrepreneurial network. By committing to personal attention, we provide each member of our concentrated portfolio with equal and essential access to innovation, capital, and community.

Learn About Our Approach

Happenings in Our Network

Portfolio News
Electra Logo

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer

October 22, 2025
Proceeds will fund a global pivotal trial of lead product candidate,...
Read More
Portfolio News
Electra Logo

Electra Therapeutics Announces First Patients Dosed in the SURPASS Phase 2/3 Pivotal Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

October 22, 2025
The SURPASS study is enrolling patients at research sites across the...
Read More
Portfolio News
Electra Logo

Electra Therapeutics Receives FDA Breakthrough Therapy and EMA Priority Medicines Designations for ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

October 22, 2025
ELA026 has demonstrated promising potential as a frontline treatment for patients...
Read More
See All the Latest

A Complementary Community

Where our visionary founders seized the opportunity to propel the Los Angeles biotech ecosystem, we’ve continued to build an increasingly symbiotic and ever-evolving community. From finding the right entrepreneurs to spearhead company formation, to scaling science through phase-appropriate R&D resources, our network provides unique complementary connections. Drawing from these roots, we support people making medical breakthroughs in California and beyond.

Thinking of the next breakthrough?

Join Our Community
  • People
  • Portfolio
  • About
  • News
  • Contact

© 2025 Westlake BioPartners. All Rights Reserved. Privacy Policy